{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:56:50Z","timestamp":1781636210080,"version":"3.54.5"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Complementary and alternative medicine use can lead to the development of membranous nephropathy (MN). The true prevalence and etiologies of complementary and alternative medicine-induced MN remain likely underestimated. The purpose of this review was to report on the incidence of MN induced by various types of complementary and alternative medicine, their clinical presentation, and treatment responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines. We performed searches in MEDLINE, Embase, PubMed, the Cochrane Library, and conducted hand searches of the reference lists. Studies reporting cases of membranous nephropathy with complementary and alternative medicine exposure published in English from 2010 were included. Two authors independently assessed study eligibility and extracted data for analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-seven studies were included (case reports [n = 10], case series [n = 10], cohort studies [n = 5], and case-control studies [n = 2]) involving a total of 262 patients (66% female) with biopsy-proven MN. The mean age of patients was 43 (\u00b114) years, and the majority of cases (70 [87.5%]) reported exposure to mercury from traditional medicines, skin-whitening creams and hair dyes. Of the 113 cases tested for neural epidermal growth factor-like 1 protein (NELL-1) antibodies, 107 (94.7%) were positive. Treatment approaches varied widely. Of those managed conservatively (54.8%), 64% achieved complete remission and 24% achieved partial remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most reported cases of complementary and alternative medicine-associated MN were in the context of mercury exposure and tested positive for NELL-1. There was no difference in clinical response between those treated with immunosuppression or conservative management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Registration<\/jats:title>\n                    <jats:p>PROSPERO Registration number: CRD42024556741<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/joneph\/aajaf036","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:32:48Z","timestamp":1779111168000},"page":"259-266","source":"Crossref","is-referenced-by-count":0,"title":["Complementary and alternative medicine-associated membranous nephropathy: a systematic review"],"prefix":"10.1093","volume":"39","author":[{"given":"Matthew Kha","family":"Nguyen","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Western Sydney University , Sydney, NSW ,","place":["Australia"]},{"name":"Department of Renal Medicine, Blacktown Hospital , Blacktown, NSW 2155"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-7170","authenticated-orcid":false,"given":"Angela","family":"Chou","sequence":"additional","affiliation":[{"name":"Nepean Kidney Research Centre, Department of Renal Medicine, Nepean Hospital , Kingswood NSW 2747 ,","place":["Australia"]},{"name":"Sydney Medical School, Faculty of Medicine and Health, The University of Sydney , Sydney, NSW 2006 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Ramachandran","sequence":"additional","affiliation":[{"name":"Post Graduate Institue of Medical Education and Research , Chandigarah ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anila Abraham","family":"Kurien","sequence":"additional","affiliation":[{"name":"Renopath, Center of Renal Urological Pathology , Chennai ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhadran","family":"Bose","sequence":"additional","affiliation":[{"name":"Nepean Kidney Research Centre, Department of Renal Medicine, Nepean Hospital , Kingswood NSW 2747 ,","place":["Australia"]},{"name":"Sydney Medical School, Faculty of Medicine and Health, The University of Sydney , Sydney, NSW 2006 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"2026061614390610500_aajaf036-B1","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1053\/j.ajkd.2015.07.006","article-title":"Atlas of renal pathology: membranous nephropathy","volume":"66","author":"Fogo","year":"2015","journal-title":"Am J Kidney Dis."},{"key":"2026061614390610500_aajaf036-B2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/9781119105954.ch16","article-title":"Membranous nephropathy","volume":"1","author":"Trinh","year":"2022","journal-title":"Evidence-Based Nephrol"},{"key":"2026061614390610500_aajaf036-B3","doi-asserted-by":"publisher","first-page":"611317","DOI":"10.3389\/fmed.2020.611317","article-title":"Secondary membranous nephropathy: a narrative review","volume":"7","author":"Moroni","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2026061614390610500_aajaf036-B4","doi-asserted-by":"publisher","first-page":"100827","DOI":"10.1016\/j.xkme.2024.100827","article-title":"Complementary and alternative medicine use and glomerular disease: a contemporary case series","volume":"6","author":"Devaraju","year":"2024","journal-title":"Kid Med"},{"key":"2026061614390610500_aajaf036-B5","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.ekir.2022.04.078","article-title":"What can mercury teach US about membranous nephropathy and minimal change disease?","volume":"7","author":"Caza","year":"2022","journal-title":"Kid Int Rep"},{"key":"2026061614390610500_aajaf036-B6","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Online)"},{"key":"2026061614390610500_aajaf036-B7","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.kint.2022.09.001","article-title":"Traditional indigenous medicines are an etiologic consideration for NELL1-positive membranous nephropathy","volume":"102","author":"Kurien","year":"2022","journal-title":"Kid Int"},{"key":"2026061614390610500_aajaf036-B8","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.ekir.2022.12.026","article-title":"Neural epidermal growth factor-like 1\u2013positive membranous nephropathy with rheumatoid arthritis","volume":"8","author":"Miyazaki","year":"2023","journal-title":"Kid Int Rep"},{"key":"2026061614390610500_aajaf036-B9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/ndt\/gfad227","article-title":"Membranous nephropathy-diagnosis and identification of target antigens","volume":"39","author":"Sethi","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026061614390610500_aajaf036-B10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.kint.2020.07.039","article-title":"NELL1 is a target antigen in malignancy-associated membranous nephropathy","volume":"99","author":"Caza","year":"2021","journal-title":"Kid Int"},{"key":"2026061614390610500_aajaf036-B11","doi-asserted-by":"publisher","first-page":"sfad228","DOI":"10.1093\/ckj\/sfad228","article-title":"Novel biomarkers and pathophysiology of membranous nephropathy: PLA2R and beyond","volume":"17","author":"Murtas","year":"2024","journal-title":"Clin Kid J"},{"key":"2026061614390610500_aajaf036-B12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1467-8519.2009.01755.x","article-title":"Racist appearance standards and the enhancements that love them: norman daniels and skin-lightening cosmetics","volume":"25","author":"Lamkin","year":"2011","journal-title":"Bioethics"},{"key":"2026061614390610500_aajaf036-B13","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.ekir.2020.06.015","article-title":"Membranous nephropathy associated with indigenous Indian medications containing heavy metals","volume":"5","author":"Kumar","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2026061614390610500_aajaf036-B14","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/ijms18051039","article-title":"Chronic kidney disease and exposure to nephrotoxic metals","volume":"18","author":"Orr","year":"2017","journal-title":"Int J Mol"},{"key":"2026061614390610500_aajaf036-B15","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.ekir.2022.03.009","article-title":"Toxic nephropathy secondary to chronic mercury poisoning: clinical characteristics and outcomes","volume":"7","author":"Gao","year":"2022","journal-title":"Kid Int Rep"},{"key":"2026061614390610500_aajaf036-B16","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.kint.2024.03.025","article-title":"NELL-1-associated membranous nephropathy linked to skin fairness cream use: insights from an Indian case series","volume":"105","author":"Narayanan","year":"2024","journal-title":"Kid Int"},{"key":"2026061614390610500_aajaf036-B17","first-page":"247","article-title":"Mercury compounds and the immune system: a review","volume":"10","author":"Moszczy\u0144ski","year":"1997","journal-title":"Int J Occup Med Environ Health"},{"key":"2026061614390610500_aajaf036-B18","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2024ma6qjre0","article-title":"Alpha lipoic acid-associated NELL1-positive membranous nephropathy: TH-PO670","volume":"35","author":"Ali","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026061614390610500_aajaf036-B19","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.ekir.2024.02.1401","article-title":"Characteristics and outcomes of NELL1 membranous nephropathy in lipoic acid users and nonusers","volume":"9","author":"Avasare","year":"2024","journal-title":"Kid Int Rep"},{"key":"2026061614390610500_aajaf036-B20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1681\/ASN.20233411S1266d","article-title":"Clinical outcome of NELL1-associated membranous nephropathy","volume":"34","author":"Ramachandran","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026061614390610500_aajaf036-B21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.nurpra.2008.12.011","article-title":"Let's talk about complementary and alternative therapies","volume":"5","author":"Koithan","year":"2009","journal-title":"J Nurse Pract"},{"key":"2026061614390610500_aajaf036-B22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fneph.2024.1323432","article-title":"Mercury-associated nephrotic syndrome: a case report and systematic review of the literature","volume":"62","author":"Miller","year":"2013","journal-title":"Am J Kidney Dis."},{"key":"2026061614390610500_aajaf036-B23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1681\/ASN.20213210S1513b","article-title":"A study comparing rituximab and modified ponticelli (MP) regimen in primary membranous nephropathy(PMN)","volume":"32","author":"Kumar","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026061614390610500_aajaf036-B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-024-03665-0","article-title":"Diagnosis and treatment of secondary nephrotic syndrome with rash as the first symptom: a case report","volume":"25","author":"Qin","year":"2024","journal-title":"BMC nephrol"},{"key":"2026061614390610500_aajaf036-B25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2215\/cjn.07571009","article-title":"Mercury-induced membranous nephropathy: clinical and pathological features","volume":"5","author":"Li","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026061614390610500_aajaf036-B26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/toxics13060507","article-title":"Analysis of mercury concentration in cosmetic clays","volume":"13","author":"Fischer","year":"2025","journal-title":"Toxics (Basel)"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/2\/259\/68322929\/aajaf036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/2\/259\/68322929\/aajaf036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:39:12Z","timestamp":1781635152000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/39\/2\/259\/8685145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5,18]]},"published-print":{"date-parts":[[2026,6,16]]}},"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajaf036","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,3]]}}}